Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Recurrence
×
Bortezomib
×
Clear all
Filters
3
NCT05519085
2026-03-11
SUCCESSOR-1
Celgene
Phase 3
Recruiting
810 enrolled
NCT02343042
2025-12-22
STOMP
Karyopharm Therapeutics Inc
Phase 1/2
Recruiting
300 enrolled